Dublin, Ireland

Kenneth Hun Mok

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Hamlet Pharma Ab. Active years: 2014-2016.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Kenneth Hun Mok

Introduction

Kenneth Hun Mok is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of biotechnology, particularly in the development of biologically active complexes. With a total of 3 patents to his name, Mok's work has opened new avenues for pharmaceutical advancements.

Latest Patents

Mok's latest patents focus on a biologically active complex and its preparation. This complex comprises either a polypeptide that is a variant of a naturally occurring protein or a peptide of up to 50 amino acids. The invention also includes a pharmaceutically acceptable salt of a fatty acid or lipid. The complexes demonstrate a novel mode of action, which presents opportunities for the development of further active agents and screening methods.

Career Highlights

Kenneth Hun Mok is currently associated with Hamlet Pharma AB, where he continues to innovate in the field of biotechnology. His work is characterized by a commitment to advancing medical science through innovative solutions.

Collaborations

Mok collaborates with esteemed colleagues such as Ann-Kristin Mossberg and Catharina Svanborg, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kenneth Hun Mok's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to inspire advancements in pharmaceutical research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…